Page 203 - ATP-P 11th Ed

Category II
a. Tightness in chest
b. Dyspnea
c. Localized or generalized fasciculations
Category III
a. Life threatening dyspnea
b. Seizures
Triage Categories (MASCAL)
No Treatment
a. Miosis SECTION 2
b. Rhinorrhea
c. Absence of any other symptoms
Category I
a. Sweating
b. Fasiculations
c. Nausea & vomiting
d. Weakness
e. Dyspnea
Category II
a. Unconsciousness
b. Convulsions
c. Apnea
d. Flaccid paralysis
Management
1. Airway management is paramount!
2. Antidote Treatment Nerve Agent, Auto-Injector (ATNAA)
a. Given intramuscularly
b. Each auto-injector contains atropine 2.1mg and pralidoxime (2PAM-Cl) 600mg
c. Number of auto-injectors given depends on symptoms
3. Convulsant Antidote for Nerve Agent (CANA)
a. Given intramuscularly
b. Each auto-injector contains 10mg of diazepam (Valium )
®
c. Number of auto-injectors given depends on symptoms
4. Dosages
a. Category I – 1 ATTNA auto injector
b. Category II – 2 ATTNA kits and 1 CANA if fasiculations are present
c. Category III – 3 ATTNA kits and 1 CANA

192 SECTION 2 TACTICAL MEDICAL EMERGENCY PROTOCOLS (TMEPs) ATP-P Handbook 11th Edition 193